U.S. News & World Report’s “Best Hospitals” ranks NYU Langone one of the top hospitals in the country for pulmonology and lung surgery.
At NYU Langone’s Bronchiectasis and Nontuberculous Mycobacteria (NTM) Program, our healthcare team uses its dedication, experience, and research know-how to provide treatments that can improve the lives and life spans of people who have chronic lung ailments.
Bronchiectasis, nontuberculous mycobacterial (NTM) infections, and cystic fibrosis affect the lungs’ ability to clear mucus from airways. This buildup of fluid affects lung function and increases the chance of infection.
Our program brings together a team of pulmonologists, gastroenterologists, infectious disease specialists, otolaryngologists, thoracic surgeons, physiatrists, respiratory therapists, physical therapists, and nutritionists who specialize in chest care to create a treatment plan that best meets the needs of each patient.
Our team is also committed to increasing education about these conditions. We host a patient education program on bronchiectasis and NTM infections that is aimed at helping patients better understand the condition and the treatment options available to them.
Nontuberculous Mycobacteria Patient Education Program
Discover the latest advances in the diagnosis and treatment of NTM infections.Learn More About Our NTM Patient Education Program
NYU Langone is a nationally recognized referral center for the treatment of people with bronchiectasis, NTM infections, and cystic fibrosis. Our physicians have treated more than 2,000 patients with these conditions, making us one of the leading care centers in the country. We are fully accredited by the Cystic Fibrosis Foundation.
We are dedicated to research in bronchiectasis, NTM, and cystic fibrosis. Our researchers conduct multidisciplinary clinical and translational research. This program enables our experts to integrate research findings with clinical care. We participate in the national research registry and have multiple clinical trials available to patients.
Our physicians are leaders in the management of bronchiectasis, nontuberculous mycobacteria infections, and cystic fibrosis. They are actively involved in research initiatives to better understand these conditions and develop new therapies.
We help children and adults with cystic fibrosis manage symptoms and offer effective therapies.
We treat people with conditions that affect the airway and make breathing difficult.
We provide cardiac and pulmonary rehabilitation.